title: Platelet factor 4 release induced by intravenous administration of heparin.
abstract: When heparin is injected intravenously, it can induce an immediate release of platelet factor 4 PF4), probably from the non-platelet pool of endothelial cells. We evaluated this release in a group of normal subjects and patients with cardiovascular disorders or thrombocytosis after an intravenous injection of a bolus of 5,000 I.U. of a commercial mucous heparin. The mean level in normals was 102 +/- 32 (range 50-160) ng/ml and no correlation was found before and after heparin injection between PF4 and heparin level, body weight or platelet count. Only three cardiovascular patients had an elevated level of PF4 released by heparin (HR-PF4) that could be the expression of an increased platelet turnover, whereas all the patients with thrombocytosis had an extremely elevated level of HR-PF4. These patients have much more PF4 available for the binding sites of endothelial cells since only a small percentage of potential binding sites are normally occupied "in vivo". Although no correlation could be found between platelet count and HR-PF4 in subjects with a normal platelet count or in patients with thrombocytosis there was a positive correlation, however, when all the cases were considered together. The other proteins with heparin affinity, B-thromboglobulin, antithrombin III and fibronectin were not influenced by a bolus of heparin and did not correlate in normals as well in patients with HR-PF4.
authors.forename: G
authors.initials: G
authors.lastname: Cella
authors.forename: N
authors.initials: N
authors.lastname: Scattolo
authors.forename: M G
authors.initials: MG
authors.lastname: Cappellato
authors.forename: A
authors.initials: A
authors.lastname: Girolami
authors.forename: W E
authors.initials: WE
authors.lastname: Strauss
authors.forename: A A
authors.initials: AA
authors.lastname: Sasahara
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000990:Antithrombin III / Q000032:analysis; D002318:Cardiovascular Diseases / Q000097:blood; D005260:Female; D005353:Fibronectins / Q000032:analysis; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010978:Platelet Factor 4 / Q000502:physiology*; D001620:beta-Thromboglobulin / Q000032:analysis
chemical_list: D005353:Fibronectins; D001620:beta-Thromboglobulin; D010978:Platelet Factor 4; D000990:Antithrombin III; D006493:Heparin